|
1.
|
原著
|
肝機能障害はCOVID-19患者の呼吸状態重症化の予測因子である 2021/07
|
|
2.
|
総説
|
NAFLD/NASHの疫学と今後の予想 2021/05
|
|
3.
|
原著
|
携帯型エコー「iViz air」の使用経験と新たな使用法の提案. 2020/06
|
|
4.
|
原著
|
NAFLD/NASHの進歩と新たな展開 疫学と今後の予想 2020/05
|
|
5.
|
原著
|
Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis. 2020/03
|
|
6.
|
原著
|
Antidiabetic Treatments for Diabetes with Liver Cirrhosis 2020/03
|
|
7.
|
原著
|
Hepatoprotective effect of SGLT2 inhibitor on nonalcoholic fatty liver diseases 2020/03
|
|
8.
|
原著
|
Estimated Prevalence of Advanced Hepatic Fibrosis by Elastography in Patients with Type 2 Diabetes 2020/02
|
|
9.
|
原著
|
Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis. 2019/09
|
|
10.
|
原著
|
Infection phase is a predictor of pruritus in patients with hepatitis B virus infection. 2019/08
|
|
11.
|
原著
|
Epidemiological survey of hemoglobin A1c and liver fibrosis in a general population with non-alcoholic fatty liver disease. 2019/03
|
|
12.
|
原著
|
New microwave ablation system for unresectable liver tumors that forms large, spherical ablation zones. 2018/12
|
|
13.
|
原著
|
Correction to: The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study. 2018/11
|
|
14.
|
原著
|
The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study. 2018/11
|
|
15.
|
原著
|
Wisteria floribunda agglutinin-positive Mac-2-binding protein and type 4 collagen 7S: useful markers for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease. 2018/10
|
|
16.
|
原著
|
Lack of 17β-estradiol reduces sensitivity to insulin in the liver and muscle of male mice. 2018/09
|
|
17.
|
原著
|
A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD. 2018/07
|
|
18.
|
原著
|
Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring. 2018/07
|
|
19.
|
原著
|
New scoring system combining the FIB-4 index and cytokeratin-18 fragments for predicting steatohepatitis and liver fibrosis in patients with nonalcoholic fatty liver disease. 2018/05
|
|
20.
|
原著
|
Are donors or recipients a more important predictive factor for the development of non-alcoholic fatty liver disease after liver transplantation? 2018/02
|
|
21.
|
原著
|
Prevalence of pruritus in patients with chronic liver disease: A multicenter study. 2018/02
|
|
22.
|
原著
|
Use of Mac-2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis. 2017/10
|
|
23.
|
原著
|
High fasting insulin concentrations may be a pivotal predictor for the severity of hepatic fibrosis beyond the glycemic status in non-alcoholic fatty liver disease patients before development of diabetes mellitus. 2017/09
|
|
24.
|
原著
|
Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS. 2017/08
|
|
25.
|
原著
|
Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study. 2017/08
|
|
26.
|
原著
|
Abnormal lipid/lipoprotein metabolism and high plasma testosterone levels in male but not female aromatase-knockout mice. 2017/05
|
|
27.
|
原著
|
Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease. 2017
|
|
28.
|
原著
|
Suppression of MicroRNA-7 (miR-7) Biogenesis by Nuclear Factor 90-Nuclear Factor 45 Complex (NF90-NF45) Controls Cell Proliferation in Hepatocellular Carcinoma. 2016/09
|
|
29.
|
原著
|
Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey. 2016/06
|
|
30.
|
原著
|
Characterization of Ovarian Responses to Equine Chorionic Gonadotropin of Aromatase-Deficient Mice With or Without 17β-Estradiol Supplementation. 2016/05
|
|
31.
|
原著
|
Patatin-like phospholipase domain-containing protein 3 is involved in hepatic fatty acid and triglyceride metabolism through X-box binding protein 1 and modulation of endoplasmic reticulum stress in mice. 2016/05
|
|
32.
|
その他
|
Are genetic variations the most important risk factors for development of hepatocellular carcinoma? 2016/04
|
|
33.
|
原著
|
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. 2016/03
|
|
34.
|
原著
|
A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers. 2015/11
|
|
35.
|
原著
|
Biphasic effect of alcohol intake on the development of fatty liver disease. 2015/11
|
|
36.
|
原著
|
Co-administration of insulin with a gonadotropin partly improves ovulatory responses of estrogen-deficient mice. 2015/08
|
|
37.
|
原著
|
Is non-alcoholic fatty liver disease a systemic disease that promotes extrahepatic cancer development? 2015/07
|
|
38.
|
原著
|
Overexpression of NF90-NF45 Represses Myogenic MicroRNA Biogenesis, Resulting in Development of Skeletal Muscle Atrophy and Centronuclear Muscle Fibers. 2015/07
|
|
39.
|
原著
|
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. 2015/04
|
|
40.
|
原著
|
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. 2015/04
|
|
41.
|
原著
|
MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis. 2015/04
|
|
42.
|
原著
|
Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J). 2015/03
|
|
43.
|
原著
|
Insulin resistance correlated with the severity of liver histology in Japanese NAFLD patients: a multicenter retrospective study. 2015/02
|
|
44.
|
原著
|
Clinical usage of serum ferritin to assess liver fibrosis in patients with non-alcoholic fatty liver disease: Proceed with caution. 2014/12
|
|
45.
|
原著
|
Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients. 2014/11
|
|
46.
|
原著
|
Upper limit of normal serum alanine aminotransferase levels in Japanese subjects. 2014/11
|
|
47.
|
原著
|
Simple scoring system for predicting cirrhosis in nonalcoholic fatty liver disease. 2014/08
|
|
48.
|
原著
|
Uric acid levels decrease with fibrosis progression in patients with nonalcoholic fatty liver disease. 2014/08
|
|
49.
|
原著
|
The association of insomnia with gastroesophageal reflux symptoms in biopsy-proven nonalcoholic fatty liver disease. 2014/07
|
|
50.
|
原著
|
Bofutsushosan, a Japanese herbal (Kampo) medicine, attenuates progression of nonalcoholic steatohepatitis in mice. 2014/06
|
|
51.
|
原著
|
Aromatase-null mice expressing enhanced green fluorescent protein in germ cells provide a model system to assess estrogen-dependent ovulatory responses. 2014/04
|
|
52.
|
原著
|
LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study. 2014
|
|
53.
|
原著
|
Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels. 2013/09
|
|
54.
|
原著
|
Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease. 2013
|
|
55.
|
原著
|
Hepatocyte destruction with enhanced collagen synthesis: characteristic feature of chronic hepatitis C patients on haemodialysis. 2013
|
|
56.
|
その他
|
Third-generation inhibitor for the renin–angiotensin system: Can it strongly protect against progression of hepatic fibrosis in non-alcoholic steatohepatitis? 2013
|
|
57.
|
原著
|
Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: An analysis of 16 346 treated nodules in 13 283 patients. 2012/11
|
|
58.
|
原著
|
17β-Estradiol is critical for the preovulatory induction of prostaglandin E(2) synthesis in mice. 2012/10
|
|
59.
|
原著
|
Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. 2012/02
|
|
60.
|
原著
|
Impact of ovarian sex steroids on ovulation and ovulatory gene induction in aromatase-null mice. 2012/01
|
|
61.
|
原著
|
High expression of nuclear factor 90 (NF90) leads to mitochondrial degradation in skeletal and cardiac muscles. 2012
|
|
62.
|
その他
|
Is impaired Kupffer cell function really important to the pathogenesis of nonalcoholic steatohepatitis? 2012
|
|
63.
|
その他
|
Is rosuvastatin effective for non-alcoholic steatohepatitis with dyslipidemia? 2012
|
|
64.
|
原著
|
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. 2012
|
|
65.
|
原著
|
Usefulness of Technetium-99 m-2-methoxy-isobutyl-isonitrile liver scintigraphy for evaluating disease activity of non-alcoholic fatty liver disease. 2012
|
|
66.
|
原著
|
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. 2012
|
|
67.
|
原著
|
A novel and comprehensive mouse model of human non-alcoholic steatohepatitis with the full range of dysmetabolic and histological abnormalities induced by gold thioglucose and a high-fat diet. 2011
|
|
68.
|
原著
|
Angiotensinogen gene haplotype is associated with the prevalence of Japanese non-alcoholic steatohepatitis. 2011
|
|
69.
|
原著
|
Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan. 2010/10
|
|
70.
|
原著
|
uper paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease. 2010
|
|
71.
|
原著
|
Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. 2007
|
|
72.
|
原著
|
Increased susceptibility to liver injury after hemorrhagic shock in rats chronically fed ethanol: role of nuclear factor-kappa B, interleukin-6, and granulocyte colony-stimulating factor. 2004
|
|
73.
|
原著
|
Transactivation of transforming growth factor alpha gene by hepatitis B virus preS1. 1998
|
|
5件表示
|
|
全件表示(73件)
|
